Navigation Links
John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference

HACKENSACK, N.J. (February 16, 2011) The Division of Breast Oncology at the John Theurer Cancer Center at Hackensack University Medical Center will host the Eighth Annual Northern New Jersey Breast Cancer Conference on Friday, February 18 from 7:00 am 3:30 pm. This free continuing medical education (CME) event will present highlights from the 34th Annual San Antonio Breast Cancer Symposium, an international scientific symposium for breast cancer basic scientists and clinicians, to tri-state area oncologists, hematologists, other physicians and healthcare professionals.

"Each year, an international gathering of leading breast oncologists attend the San Antonio Breast Cancer Symposium to discuss the latest research and treatment methods in breast cancer," said Stanley Waintraub, M.D., F.A.C.P., Co-Chief of Breast Oncology at the John Theurer Cancer Center. "The Eighth Annual Northern New Jersey Breast Cancer Conference provides area physicians and healthcare professionals an opportunity to learn the latest breast cancer research findings so they can apply these learnings to the clinic."

The conference will take place in Hackensack University Medical Center's Hekemian Conference Center and is worth a maximum of 6.0 AMA PRA Category 1 Credits. Topics to be covered include breast cancer screening policy, conflicting viewpoints in newer treatments for advanced breast cancer, radiation therapy in lymph node involvement, neoadjuvant therapy, clinical trials, genomic & molecular profiling, emerging targeted therapies, and use of hormonal therapies before and after diagnosis.

"Education is paramount in advancing research and providing patients with cutting-edge care," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services at Hackensack University Medical Center. "Collaborating with leading experts from outside institutions is key in delivering the best education and updates to our staff and the local healthcare community."

Featured Speakers at this conference include:

  • Stanley E. Waintraub, M.D., F.A.C.P., Co-Chief of Breast Oncology, John Theurer Cancer Center
  • Freya R. Schnabel, M.D., Professor of Surgery, NYU School of Medicine
  • Mary Elizabeth Cianfrocca, D.O., Feinberg School of Medicine, Northwestern University
  • Lawrence J. Solin, M.D., F.A.C.R., Chairman of Radiation Oncology, Albert Einstein Medical Center
  • Howard A. Burris, M.D., Director of Drug Development, Sarah Cannon Research Institute
  • Edith A. Perez, M.D., Director of Breast Program and Professor of Medicine, Mayo Clinic
  • Adam Brufsky, M.D., Ph.D., Associate Chief of the Division of Hematology/Oncology and Professor of Medicine, University of Pittsburgh
  • Brian Leyland-Jones, M.D., Director, Emory Winship Cancer Institute, Emory University
  • Harold A. Harvey, M.D., Director, Professor of Medicine and Director, Hematology/Oncology Fellowship Program, Milton S. Hershey Medical Center

This CME conference is free and directed primarily for medical oncologists and hematologists, as well as nurses and other healthcare professionals in the oncology field who are interested in the treatment of breast cancer. To register in advance, please contact Bonnie LoGiudice at 201-996-4891 or


Contact: Amy Leahing
John Theurer Cancer Center

Related medicine news :

1. Oncology basic research director at John Theurer Cancer Center continues transplantation research
2. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
3. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
4. John Theurer Cancer Center to present innovative research at 2 surgical meetings
5. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
6. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
7. The John Theurer Cancer Center recognizes medical physics team for safety track record
8. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
9. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
10. John Theurer Cancer Center offers breakthrough radiation measurement technology
11. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
Breaking Medicine Technology: